Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Pediatric Perfusion Market, by End Use
1.4.2 Europe Pediatric Perfusion Market, by Product
1.4.3 Europe Pediatric Perfusion Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter Five Forces Analysis
Chapter 4. Strategies Deployed in Pediatric Perfusion Market
Chapter 5. Europe Pediatric Perfusion Market by End-use
5.1 Europe Hospitals Market by Country
5.2 Europe Cardiac Centers Market by Country
5.3 Europe Others Market by Country
Chapter 6. Europe Pediatric Perfusion Market by Product
6.1 Europe Pediatric Oxygenators Market by Country
6.2 Europe Pediatric Cannulae Market by Country
6.3 Europe Pediatric Blood Pumps Market by Country
6.4 Europe Pediatric Arterial Filters Market by Country
6.5 Europe Monitoring Systems Market by Country
6.6 Europe Others Market by Country
Chapter 7. Europe Pediatric Perfusion Market by Country
7.1 Germany Pediatric Perfusion Market
7.1.1 Germany Pediatric Perfusion Market by End-use
7.1.2 Germany Pediatric Perfusion Market by Product
7.2 UK Pediatric Perfusion Market
7.2.1 UK Pediatric Perfusion Market by End-use
7.2.2 UK Pediatric Perfusion Market by Product
7.3 France Pediatric Perfusion Market
7.3.1 France Pediatric Perfusion Market by End-use
7.3.2 France Pediatric Perfusion Market by Product
7.4 Russia Pediatric Perfusion Market
7.4.1 Russia Pediatric Perfusion Market by End-use
7.4.2 Russia Pediatric Perfusion Market by Product
7.5 Spain Pediatric Perfusion Market
7.5.1 Spain Pediatric Perfusion Market by End-use
7.5.2 Spain Pediatric Perfusion Market by Product
7.6 Italy Pediatric Perfusion Market
7.6.1 Italy Pediatric Perfusion Market by End-use
7.6.2 Italy Pediatric Perfusion Market by Product
7.7 Rest of Europe Pediatric Perfusion Market
7.7.1 Rest of Europe Pediatric Perfusion Market by End-use
7.7.2 Rest of Europe Pediatric Perfusion Market by Product
Chapter 8. Company Profiles
8.1 Medtronic PLC
8.1.1 Company overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.6 SWOT Analysis
8.2 LivaNova PLC
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 SWOT Analysis
8.3 Terumo Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Acquisition and Mergers:
8.3.6 SWOT Analysis
8.4 BL Lifesciences (BL group of family companies)
8.4.1 Company Overview
8.4.2 SWOT Analysis
8.5 Cardinal Health, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 SWOT Analysis
8.6 EUROSETS S.R.L. (GVM Care Research)
8.6.1 Company Overview
8.6.2 SWOT Analysis
8.7 Getinge AB
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 SWOT Analysis
8.8 Koninklijke Philips N.V.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.8.5.2 Product Launches and Product Expansions:
8.8.6 SWOT Analysis
8.9 Nonin Medical, Inc.
8.9.1 Company Overview
8.10. GE HealthCare Technologies, Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 SWOT Analysis
Unique Offerings 